Scabies

Lancet

Volumn 367, Issue 9524, 2006, Pages 1767-1774

  Heukelbach, Jörg ^a   Feldmeier, Hermann ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; AZADIRACHTA INDICA EXTRACT; BENZYL BENZOATE; CROTAMITON; CURCUMA LONGA EXTRACT; ESSENTIAL OIL; IVERMECTIN; LINDANE; LIPPIA MULTIFLORA EXTRACT; MALATHION; PERMETHRIN; PYRETHROID; SULFIRAM; SULFUR; TEA TREE OIL; TURMERIC; UNCLASSIFIED DRUG;

ALLERGIC GLOMERULONEPHRITIS; ANXIETY; AZADIRACHTA INDICA; BURNING SENSATION; CLINICAL FEATURE; CLINICAL TRIAL; CONVULSION; CROWDING; CURCUMA LONGA; DELAYED DIAGNOSIS; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; DRUG FATALITY; DRUG MECHANISM; EDUCATION PROGRAM; EPILUMINESCENCE MICROSCOPY; HUMAN; IMMUNE RESPONSE; LIFE CYCLE; NEUROLOGIC DISEASE; NONHUMAN; PARASITE TRANSMISSION; PARASITOSIS; PARESTHESIA; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; POVERTY; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SARCOPTES SCABIEI; SCABIES; SIDE EFFECT; SKIN IRRITATION; SOCIOECONOMICS; SUPERINFECTION; TREMOR; UNSPECIFIED SIDE EFFECT;

EID: 33646797008     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68772-2     Document Type: Review

References (137)

1. Ramos-e-Silva M. Giovan Cosimo Bonomo 1663-1696: discoverer of the etiology of scabies. Int J Dermatol 37 (1998) 625-630
2. Mellanby K. Biology of the parasite. In: Orkin M., and Maibach H. (Eds). Cutaneous infestations and insect bites (1985), Marcel Dekker, New York 9-18
3. Arlian L. Biology, host relations, and epidemiology of Sarcoptes scabiei. Annu Rev Entomol 34 (1989) 139-161
4. Arlian L., Runyan R., Achar S., and Estes S. Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol 11 (1984) 210-215
5. Arlian L., Vyszenski-Moher D., and Pole M. Survival of adults and development stages of Sarcoptes scabiei var. canis when off the host. Exp Appl Acarol 6 (1989) 181-187
6. Chakrabarti A. Some epidemiological aspects of animal scabies in human population. Int J Zoonoses 12 (1985) 39-52
7. Walton S., and Holt D. Scabies: new future for a neglected disease. Adv Parasitol 57 (2004) 309-376
8. Rehbein S., Visser M., Winter R., et al. Productivity effects of bovine mange and control with ivermectin. Vet Parasitol 114 (2003) 267-284
9. Pence D., and Ueckermann E. Sarcoptic mange in wildlife. Rev Sci Tech 21 (2002) 385-398
10. Fain A. Epidemiological problems of scabies. Int J Dermatol 17 (1978) 20-30
11. Arlian L., Runyan R., and Estes S. Cross infestivity of Sarcoptes scabiei. J Am Acad Dermatol 10 (1984) 979-986
12. Morsy T., Bakr M., Ahmed M., and Kotb M. Human scabies acquired from a pet puppy. J Egypt Soc Parasitol 24 (1994) 305-308
13. Mitra M., Mahanta S., Sen S., Ghosh C., and Hati A. Sarcoptes scabiei in animals spreading to man. Trop Geogr Med 45 (1993) 142-143
14. Burgess I. Sarcoptes scabiei and scabies. Adv Parasitol 33 (1994) 235-292
15. Heilesen B. Studies on Acarus scabiei and scabies. Acta Derm Venereol 26 (1946) 26-30
16. Mellanby K. The development of symptoms, parasitic infection and immunity in human scabies. Parasitology 35 (1944) 197-206
17. Mellanby K. The transmission of scabies. Br Med J 2 (1941) 405-406
18. McCarthy J., Kemp D., Walton S., and Currie B. Scabies: more than just an irritation. Postgrad Med J 80 (2004) 382-387
19. Roberts L., Huffam S., Walton S., and Currie B. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 50 (2005) 375-381
20. Downs A., Harvey I., and Kennedy C. The epidemiology of head lice and scabies in the UK. Epidemiol Infect 122 (1999) 471-477
21. Lonc E., and Okulewicz A. Scabies and head-lice infestations in different environmental conditions of Lower Silesia, Poland. J Parasitol 86 (2000) 170-171
22. Green M. Epidemiology of scabies. Epidemiol Rev 11 (1989) 126-150
23. Kristensen J. Scabies and Pyoderma in Lilongwe, Malawi. Prevalence and seasonal fluctuation. Int J Dermatol 30 (1991) 699-702
24. Estrada B. Ectoparasitic infestations in homeless children. Semin Pediatr Infect Dis 14 (2003) 20-24
25. Currie B., Connors C., and Krause V. Scabies programs in Aboriginal communities. Med J Aust 161 (1994) 637
26. Terry B., Kanjah F., Sahr F., Kortequee S., Dukulay I., and Gbakima A. Sarcoptes scabiei infestation among children in a displacement camp in Sierra Leone. Public Health 115 (2001) 208-211
27. Andrews J., and Tonkin S. Scabies and pediculosis in Tokelau Island children in New Zealand. J R Soc Health 109 (1989) 199-203
28. Mellanby K. Epidemiology of scabies. In: Orkin M., and Maibach H. (Eds). Cutaneous infestations and insect bites (1985), Marcel Dekker, New York 71-74
29. Heukelbach J., Wilcke T., Winter B., and Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol 153 (2005) 150-156
30. Mimouni D., Ankol O., Davidovitch N., Gdalevich M., Zangvil E., and Grotto I. Seasonality trends of scabies in a young adult population: a 20-year follow-up. Br J Dermatol 149 (2003) 157-159
31. Herrmann W., and Humann B. Jahreszeitliche Morbiditätsschwankungen bei der Scabies (Seasonal morbidity variation in scabies). Hautarzt 20 (1969) 467
32. Christophersen J. The epidemiology of scabies in Denmark, 1900 to 1975. Arch Dermatol 114 (1978) 747-750
33. Andrews J. Scabies in New Zealand. Int J Dermatol 18 (1979) 545-552
34. Tuzun Y., Kotogyan A., Cenesizoglu E., et al. The epidemiology of scabies in Turkey. Int J Dermatol 19 (1980) 41-44
35. Downs A. Seasonal variation in scabies. Br J Dermatol 150 (2004) 602-603
36. Buczek A., Pabis B., Bartosik K., Stanislawek I., Salata M., and Pabis A. Epidemiological study of scabies in different environmental conditions in central Poland. Ann Epidemiol (2005). DOI:10.1016/j.annepidem.2005.06.058
37. Stanton B., Khanam S., Nazrul H., Nurani S., and Khair T. Scabies in urban Bangladesh. J Trop Med Hyg 90 (1987) 219-226
38. Porter M. Seasonal change and its effect on the prevalence of infectious skin disease in a Gambian village. Trans R Soc Trop Med Hyg 74 (1979) 162-168
39. Lalli P., Morgan M., and Arlian L. Skewed Th1/Th2 immune response to Sarcoptes scabiei. J Parasitol 90 (2004) 711-714
40. Arlian L., Morgan M., Estes S., Walton S., Kemp D., and Currie B. Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol 41 (2004) 74-77
41. Heukelbach J., Walton S., and Feldmeier H. Ectoparasitic infestations. Curr Infect Dis Rep 7 (2005) 373-380
42. Ljunggren E., Nilsson D., and Mattsson J. Expressed sequence tag analysis of Sarcoptes scabiei. Parasitology 127 (2003) 139-145
43. Mattsson J., Ljunggren E., and Bergstrom K. Paramyosin from the parasitic mite Sarcoptes scabiei: cDNA cloning and heterologous expression. Parasitology 122 (2001) 555-562
44. Harumal P., Morgan M., Walton S., et al. Identification of a homologue of a house dust mite allergen in a cDNA library from Sarcoptes scabiei var hominis and evaluation of its vaccine potential in a rabbit/S. scabiei var. canis model. Am J Trop Med Hyg 68 (2003) 54-60
45. Fischer K., Holt D., Harumal P., Currie B., Walton S., and Kemp D. Generation and characterization of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg 68 (2003) 61-64
46. Holt D., Fischer K., Allen G., et al. Mechanisms for a novel immune evasion strategy in the scabies mite Sarcoptes scabiei: A multigene family of inactivated serine proteases. J Investig Derm 121 (2003) 1419-1424
47. Holt D., Fischer K., Pizzutto S., Currie B., Walton S., and Kemp D. A multigene family of inactivated cysteine proteases in Sarcoptes scabiei. J Investig Derm 123 (2004) 240-241
48. Pettersson E., Ljunggren E., Morrison D., and Mattsson J. Functional analysis and localisation of a delta-class glutathione S-transferase from Sarcoptes scabiei. Int J Parasitol 35 (2005) 39-48
49. Brites C., Weyll M., Pedroso C., and Badaro R. Severe and Norwegian scabies are strongly associated with retroviral HIV-1/HTLV-1 infection in Bahia, Brazil. AIDS 16 (2002) 1292-1293
50. Degelau J. Scabies in long-term care facilities. Infect Control Hosp Epidemiol 13 (1992) 421-425
51. Cestari T., and Martignago B. Scabies, pediculosis, bedbugs, and stinkbugs: uncommon presentations. Clin Dermatol 23 (2005) 545-554
52. Potter E., Earle D., Mayon-White R., Poon-King T., Svartman M., and Abidh S. Acute glomerulonephritis as a complication of scabies. In: Orkin M., and Maibach H. (Eds). Cutaneous infestations and insect bites (1985), Marcel Dekker, New York 49-61
53. Currie B., and Carapetis J. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol 41 (2000) 139-143
54. Rajajee S. Post-streptococcal acute glomerulonephritis: a clinical, bacteriological and serological study. Indian J Pediatr 57 (1990) 775-780
55. Wong L., Amega B., Connors C., et al. Outcome of an interventional program for scabies in an Indigenous community. Med J Aust 175 (2001) 367-370
56. Svartman M., Potter E., Poon-King T., and Earle D. Streptococcal infection of scabetic lesions related to acute glomerulonephritis in Trinidad. J Lab Clin Med 81 (1973) 182-193
57. Berrios X. Reflexiones sobre un brote epidémico de glomerulonefritis aguda postestreptocócica (Epidemic outbreak of acute post-streptococcal glomerulonephritis). Rev Chil Pediatr 61 (1990) 109-112
58. Reid H., Bassett D., Gaworzewska E., Colman G., and Poon-King T. Streptococcal serotypes newly associated with epidemic post-streptococcal acute glomerulonephritis. J Med Microbiol 32 (1990) 111-114
59. Whittle H., Abdullahi M., Fakunle F., Parry E., and Rajkovic A. Scabies, pyoderma and nephritis in Zaria, Nigeria. A clinical and epidemiological study. Trans R Soc Trop Med Hyg 67 (1973) 349-363
60. Verma K., Chugh T., and Bhatia K. Bacteriology and urinary changes in infected scabies. Indian J Med Res 77 (1983) 447-450
61. Svartman M., Finklea J., Earle D., Potter E., and Poon-King T. Epidemic scabies and acute glomerulonephritis in Trinidad. Lancet 1 (1972) 249-251
62. Poon-King T., Svartman M., Mohammed I., et al. Epidemic acute nephritis with reappearance of M-type 55 streptococci in Trinidad. Lancet 1 (1973) 475-479
63. Reid H., Birju B., Holder Y., Hospedales J., and Poon-King T. Epidemic scabies in four Caribbean islands, 1981-1988. Trans R Soc Trop Med Hyg 84 (1990) 298-300
64. Lawrence G., Leafasia K., Sheridan J., et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 83 (2005) 34-42
65. Currie B., and Brewster D. Rheumatic fever in Aboriginal children. J Paediatr Child Health 38 (2002) 223-225
66. Hulbert T., and Larsen R. Hyperkeratotic Norwegian scabies with gram-negative bacteremia as the initial presentation of AIDS. Clin Infect Dis 14 (1992) 1164-1165
67. Micali G., Lacarrubba F., and Lo G. Scraping versus videodermatoscopy for the diagnosis of scabies: a comparative study. Acta Derm Venereol 79 (1999) 396
68. Lacarrubba F., Musumeci M., Caltabiano R., Impallomeni R., West D., and Micali G. High-magnification videodermatoscopy: a new noninvasive diagnostic tool for scabies in children. Pediatr Dermatol 18 (2001) 439-441
69. Micali G., Lacarrubba F., and Tedeschi A. Videodermatoscopy enhances the ability to monitor efficacy of scabies treatment and allows optimal timing of drug application. J Eur Acad Dermatol Venereol 18 (2004) 153-154
70. Haas N., and Sterry W. The use of ELM to monitor the success of antiscabietic treatment. Epiluminescence light microscopy. Arch Dermatol 137 (2001) 1656-1657
71. Feldmeier H., Singh C., and Guerra H. Pyoderma, group A streptococci and parasitic skin diseases-a dangerous relationship. Trop Med Int Health 10 (2005) 713-716
72. Bastian H., Lindgren A., and Alarcon G. Scabies mimicking systemic lupus erythematosus. Am J Med 102 (1997) 305-306
73. Brar B., Pall A., and Gupta R. Bullous scabies mimicking bullous pemphigoid. J Dermatol 30 (2003) 694-696
74. Burch J., Krol A., and Weston W. Sarcoptes scabiei infestation misdiagnosed and treated as Langerhans cell histiocytosis. Pediatr Dermatol 21 (2004) 58-62
75. Mauleon-Fernandez C., Saez-de-Ocariz M., Rodriguez-Jurado R., Duran-McKinster C., Orozco-Covarrubias L., and Ruiz-Maldonado R. Nodular scabies mimicking urticaria pigmentosa in an infant. Clin Exp Dermatol 30 (2005) 595-596
76. Duran C., Tamayo L., de la Luz O., and Ruiz-Maldonado R. Scabies of the scalp mimicking seborrheic dermatitis in immunocompromised patients. Pediatr Dermatol 10 (1993) 136-138
77. Gach J., and Heagerty A. Crusted scabies looking like psoriasis. Lancet 356 (2000) 650
78. Chambliss M. Treating asymptomatic bodily contacts of patients with scabies. Arch Fam Med 9 (2000) 473-474
79. Walker G., and Johnstone P. Interventions for treating scabies. Cochrane Database Syst Rev 2 (2000) CD000320
80. Johnston G., and Sladden M. Scabies: diagnosis and treatment. BMJ 331 (2005) 619-622
81. Chosidow O. Scabies and pediculosis. Lancet 355 (2000) 819-826
82. Bigby M. A systematic review of the treatment of scabies. Arch Dermatol 136 (2000) 387-389
83. Roos T., Alam M., Roos S., Merk H., and Bickers D. Pharmacotherapy of ectoparasitic infections. Drugs 61 (2001) 1067-1088
84. Elgart M. Current treatments for scabies and pediculosis. Skin Therapy Lett 5 (1999) 1-3
85. Kissmeyer A. Rapid ambulatory treatment of scabies with benzyl benzoate lotion. Lancet i (1937) 21
86. Franz T., Lehman P., Franz S., and Guin J. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 132 (1996) 901-905
87. Purvis R., and Tyring S. An outbreak of lindane-resistant scabies treated successfully with permethrin 5% cream. J Am Acad Dermatol 25 (1991) 1015-1016
88. Judd L. Gamma benzene hexachloride resistant scabies. N Z Med J 106 (1993) 61-63
89. Taplin D., Porcelain S., Meinking T., et al. Community control of scabies: a model based on use of permethrin cream. Lancet 337 (1991) 1016-1018
90. Walton S., Myerscough M., and Currie B. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg 94 (2000) 92-96
91. Amerio P., Capizzi R., and Milani M. Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs permethrin cream. Eur J Dermatol 13 (2003) 69-71
92. Bhalla M., and Thami G. Reversible neurotoxicity after an overdose of topical lindane in an infant. Pediatr Dermatol 21 (2004) 597-599
93. Solomon L., Fahrner L., and West D. Gamma benzene hexachloride toxicity: a review. Arch Dermatol 113 (1977) 353-357
94. Davies J., Dedhia H., Morgade C., Barquet A., and Maibach H. Lindane poisonings. Arch Dermatol 119 (1983) 142-144
95. Boffa M., Brough P., and Ead R. Lindane neurotoxicity. Br J Dermatol 133 (1995) 1013
96. Elgart M. A risk-benefit assessment of agents used in the treatment of scabies. Drug Saf 14 (1996) 386-393
97. Unintentional topical lindane ingestions-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54 (2005) 533-535
98. Labeling changes for Lindane. FDA Consum 37 (2003) 6
99. Quarterman M., and Lesher J. Neonatal scabies treated with permethrin 5% cream. Pediatr Dermatol 11 (1994) 264-266
100. Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J 81 (2005) 7-11
101. Buffet M., and Dupin N. Current treatments for scabies. Fundam Clin Pharmacol 17 (2003) 217-225
102. Heukelbach J., and Feldmeier H. Ectoparasites-the underestimated realm. Lancet 363 (2004) 889-891
103. Walton S., McKinnon M., Pizzutto S., Dougall A., Williams E., and Currie B. Acaricidal activity of Melaleuca alternifolia tea tree oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 140 (2004) 563-566
104. Charles V., and Charles S. The use and efficacy of Azadirachta indica ADR 'Neem' and Curcuma longa 'Turmeric' in scabies. A pilot study. Trop Geogr Med 44 (1992) 178-181
105. Oladimeji F., Orafidiya O., Ogunniyi T., and Adewunmi T. Pediculocidal and scabicidal properties of Lippia multiflora essential oil. J Ethnopharmacol 72 (2000) 305-311
106. Burkhart K., Burkhart C., and Burkhart C. Our scabies treatment is archaic, but ivermectin has arrived. Int J Dermatol 37 (1998) 76-77
107. Richard-Lenoble D., Chandenier J., and Gaxotte P. Ivermectin and filariasis. Fundam Clin Pharmacol 17 (2003) 199-203
108. del Giudice P., Chosidow O., and Caumes E. Ivermectin in dermatology. J Drugs Dermatol 2 (2003) 13-21
109. Madan V., Jaskiran K., Gupta U., and Gupta D. Oral ivermectin in scabies patients: a comparison with 1% topical lindane lotion. J Dermatol 28 (2001) 481-484
110. Chouela E., Abeldano A., Pellerano G., et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 135 (1999) 651-655
111. Glaziou P., Cartel J., Alzieu P., Briot C., Moulia-Pelat J., and Martin P. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 44 (1993) 331-332
112. Nnoruka E., and Agu C. Successful treatment of scabies with oral ivermectin in Nigeria. Trop Doct 31 (2001) 15-18
113. Brooks P., and Grace R. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health 38 (2002) 401-404
114. Usha V., and Gopalakrishnan Nair T. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 42 (2000) 236-240
115. Barkwell R., and Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 349 (1997) 1144-1145
116. Coyne P., and Addiss D. Deaths associated with ivermectin for scabies. Lancet 350 (1997) 215-216
117. Alexander N., Bockarie M., Kastens W., Kazura J., and Alpers M. Absence of ivermectin-associated excess deaths. Trans R Soc Trop Med Hyg 92 (1998) 342
118. Reintjes R., and Hoek C. Deaths associated with ivermectin for scabies. Lancet 350 (1997) 215
119. Elgart G., and Meinking T. Ivermectin. Dermatol Clin 21 (2003) 277-282
120. del Giudice P., Marty P., Gari-Toussaint M., and Le Fichoux Y. Ivermectin in elderly patients. Arch Dermatol 135 (1999) 351-352
121. Alberici F., Pagani L., Ratti G., and Viale P. Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies. Br J Dermatol 142 (2000) 969-972
122. Leppard B., and Naburi A. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol 143 (2000) 520-523
123. Millership S., Readman R., and Bracebridge S. Use of ivermectin, given orally, to control scabies in homes for the elderly mentally ill. Commun Dis Public Health 5 (2002) 144-146
124. Patel A., Hogan P., and Walder B. Crusted scabies in two immunocompromised children: successful treatment with oral ivermectin. Australas J Dermatol 40 (1999) 37-40
125. Corbett E., Crossley I., Holton J., Levell N., Miller R., and De Cock K. Crusted "Norwegian" scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med 72 (1996) 115-117
126. Bockarie M., Alexander N., Kazura J., Bockarie F., Griffin L., and Alpers M. Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea. Acta Trop 75 (2000) 127-130
127. Heukelbach J., Winter B., Wilcke T., et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ 82 (2004) 563-571
128. Heukelbach J., de Oliveira F., and Feldmeier H. Ectoparasitoses e saúde pública: desafios para controle (Ectoparasitoses and public health: challenges for control). Cad Saude Publica 19 (2003) 1535-1540
129. Currie B., Harumal P., McKinnon M., and Walton S. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 39 (2004) e8-e12
130. Figueroa J., Fuller L., Abraha A., and Hay R. Dermatology in southwestern Ethiopia: rationale for a community approach. Int J Dermatol 37 (1998) 752-758
131. Hegazy A., Darwish N., Abdel-Hamid I., and Hammad S. Epidemiology and control of scabies in an Egyptian village. Int J Dermatol 38 (1999) 291-295
132. Odueko O., Onayemi O., and Oyedeji G. A prevalence survey of skin diseases in Nigerian children. Niger J Med 10 (2001) 64-67
133. Gibbs S. Skin disease and socio-economic conditions in rural Africa: Tanzania. Int J Dermatol 35 (1996) 633-639
134. Heukelbach J., van Haeff E., Rump B., Wilcke T., Moura R., and Feldmeier H. Parasitic skin diseases: health care-seeking in a slum in north-east Brazil. Trop Med Int Health 8 (2003) 368-373
135. Carapetis J., Connors C., Yarmirr D., Krause V., and Currie B. Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 16 (1997) 494-499
136. Haas N., Wagemann B., Hermes B., Henz B., Heile C., and Schein E. Crossreacting IgG antibodies against fox mite antigens in human scabies. Arch Dermatol Res 296 (2005) 327-331
137. Bezold G., Lange M., Schiener R., et al. Hidden scabies: diagnosis by polymerase chain reaction. Br J Dermatol 144 (2001) 614-618